- Investing Ideas
- French Pharmaceuticals & Biotech Buy the Dip
French Pharmaceuticals & Biotech Buy the Dip
Results
2
2 new
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
2 companies
MedinCell
Market Cap: €973.0m
A clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France.
New
MEDCL
€27.10
7D
-8.2%
1Y
69.0%
Cellectis
Market Cap: €188.0m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
New
ALCLS
€2.59
7D
-9.2%
1Y
91.0%